Setup and characterization of a human head and neck squamous cell carcinoma xenograft model in nude rats
Objective
To develop and characterize a new head and neck cancer animal model.
Study design
A human head and neck squamous cell carcinoma (HNSCC) xenograft model in nude rats was established via subcutaneous inoculation of a human-origin HNSCC cell line, SCC-4. The tumor was evaluated for growth characteristics, pathologic features by hematoxylin-eosin (HE) staining, and immunohistochemistry of epidermal growth factor receptor (EGFR). 2-[18F] fluoro-2-deoxy-D-glucose (18F-FDG) positron emission tomography (PET) imaging characteristics were studied too.
Results
A new HNSCC animal model was successfully established. Tumor sizes reached about 1 cm3 on day 15 after tumor cell inoculation. HE staining pathology has confirmed that this tumor is a typical SCC. EGFR immunohistochemistry demonstrated this tumor model to be strongly EGFR positive. 18F-FDG PET study has shown that 18F-FDG accumulated in tumors.
Conclusions
This study has demonstrated that this tumor model is an appropriate HNSCC tumor model for animal studies on HNSCC.
aDepartment of Otolaryngology–Head and Neck Surgery; University of Texas Health Science Center at San Antonio, San Antonio, Texas
bDepartment of Radiology; University of Texas Health Science Center at San Antonio, San Antonio, Texas
cDepartment of Pathology; University of Texas Health Science Center at San Antonio, San Antonio, Texas
dDepartment of Radiation Oncology; University of Texas Health Science Center at San Antonio, San Antonio, Texas
Reprint requests: Ande Bao, PhD, University of Texas Health Science Center at San Antonio, Department of Otolaryngology–Head and Neck Surgery, 7703 Floyd Curl Drive, San Antonio, TX 78229-3900.
1 Randal Otto, MD, is a consultant for Nanospectra Biosciences and Aventis, and is a speaker for Bayer.